Sonoma Pharmaceuticals special meeting cancelled after quorum not achieved

Sonoma Pharmaceuticals, Inc.

Adjourned special meeting on Aug 19, 2026 cancelled; no quorum (1,157,852 of 3,473,554 shares needed).
Record date Apr 28, 2026; company will not solicit additional proxies.
Meeting adjournment follows failed quorum; no vote results or proposals disclosed.

item 5.07

Sonoma Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-26-006608

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.